China backs ambitious plan to foster biotech industry

China's government plans to continue to foster the growth of the country's biotech sector. Anxious to see the industry continue its blistering pace of development, officials say they can double the sector's share of GDP by 2015. By 2020, they add, biotech will be a pillar of the country's economy. New medicines and biofuels are getting the lion's share of the attention, critical elements as China upgrades its economy and looks to clean tech industries to contribute more to the economy. Story

 

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.